Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2024. The report specifically details a transaction in the company's own shares executed on August 19, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 797,653 ordinary shares
- Purpose: Cancellation
- Highest Price Paid: 372.90 pence per share
- Lowest Price Paid: 368.50 pence per share
- Volume Weighted Average Price: 371.3917 pence per share
- Post-Transaction Share Capital: 9,127,956,046 ordinary shares
Material Changes
The primary material change reported is the reduction in the company's registered share capital following the cancellation of 797,653 shares. The filing does not provide comparative data against a prior period for financial performance.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or discussion of risks and contingencies. It serves as a regulatory disclosure of a completed transaction in accordance with the Market Abuse Regulation (Regulation (EU) No 596/2014).
Investor Verification Checklist
- Verify the total number of shares purchased to date under the August 1, 2024, Buyback Programme.
- Confirm the remaining authorized buyback limit and the programme's end date.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction details.
- Check subsequent filings for updates on the total share count and capital structure.